About Samara Braunstein
Form D filings for Candesant Biomedical from 2020 to 2023 list Samara Braunstein as director.
Samara Braunstein first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Samara Braunstein in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Samara Braunstein works with at each company, as listed on that company's latest Form D.
Candesant Biomedical, Inc. · Form D, Jun 6, 2023
KL
Karen Long
Director
BH
Brad Hauser
Director
NH
Niquette Hunt
President and Chief Executive Officer, director
MK
Mary Beth Kreissler
Executive officer
MK
Michael Kane
Director
EM
Eileen McGuire
Director